The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Bromo-3-[(5-chloro-2-pyridyl)carbamoyl]-2-[(1-isopropylpiperidine-4-carbonyl)amino]phenyl b-D-glucopyranosiduronic acid ID: ALA3354240
PubChem CID: 57594784
Max Phase: Preclinical
Molecular Formula: C27H32BrClN4O9
Molecular Weight: 671.93
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)N1CCC(C(=O)Nc2c(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)cc(Br)cc2C(=O)Nc2ccc(Cl)cn2)CC1
Standard InChI: InChI=1S/C27H32BrClN4O9/c1-12(2)33-7-5-13(6-8-33)24(37)32-19-16(25(38)31-18-4-3-15(29)11-30-18)9-14(28)10-17(19)41-27-22(36)20(34)21(35)23(42-27)26(39)40/h3-4,9-13,20-23,27,34-36H,5-8H2,1-2H3,(H,32,37)(H,39,40)(H,30,31,38)/t20-,21-,22+,23-,27+/m0/s1
Standard InChI Key: FBJRMUJFXZHZGF-XJYXAJQWSA-N
Molfile:
RDKit 2D
42 45 0 0 0 0 0 0 0 0999 V2000
19.5368 -13.7387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9410 -12.8926 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.3762 -13.6862 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4051 -15.3224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2699 -14.9554 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7776 -16.4325 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.2540 -14.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9561 -13.7079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6742 -14.1093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6914 -14.9280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9893 -15.3510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0009 -16.1684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8826 -12.9347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8814 -13.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5895 -14.1632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2991 -13.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2963 -12.9311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5877 -12.5258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1748 -12.5263 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.0075 -14.1612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7146 -13.7515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4229 -14.1590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7133 -12.9343 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4196 -14.9747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1271 -15.3821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8351 -14.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8312 -14.1509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1231 -13.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1176 -12.9300 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8225 -12.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8170 -11.6995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5330 -12.9205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5255 -11.2876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5219 -10.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8133 -10.0663 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1065 -10.4785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1084 -11.2983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8108 -9.2491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5173 -8.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1019 -8.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1280 -16.1993 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
20.3337 -16.6536 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6 12 1 0
11 5 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 1
7 1 1 1
8 2 1 6
9 3 1 1
10 4 1 6
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
13 19 1 0
16 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 22 1 0
28 29 1 0
29 30 1 0
30 31 1 0
30 32 2 0
31 33 1 0
31 37 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
35 38 1 0
38 39 1 0
38 40 1 0
25 41 1 0
27 1 1 0
12 42 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 671.93Molecular Weight (Monoisotopic): 670.1041AlogP: 2.08#Rotatable Bonds: 8Polar Surface Area: 190.78Molecular Species: ZWITTERIONHBA: 10HBD: 6#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 2.42CX Basic pKa: 9.37CX LogP: -0.67CX LogD: -0.67Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -0.60
References 1. Ishihara T, Koga Y, Mori K, Sugasawa K, Iwatsuki Y, Hirayama F.. (2014) Novel strategy to boost oral anticoagulant activity of blood coagulation enzyme inhibitors based on biotransformation into hydrophilic conjugates., 22 (22): [PMID:25438755 ] [10.1016/j.bmc.2014.09.059 ]